Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 36,024 | 34,670 | 34,233 | 31,434 | 31,762 |
| Cost of Goods | 10,518 | 8,444 | 9,885 | 18,208 | 20,158 |
| Gross Profit | 25,506 | 26,226 | 24,348 | 13,226 | 11,604 |
| Operating Expenses | 32,469 | 31,468 | 35,453 | 38,363 | 54,165 |
| Operating Income | -6,445 | -4,798 | -10,220 | -24,929 | -42,403 |
| Other Income | -2,790 | 1,638 | -504 | -79 | 344 |
| Pre-tax Income | -9,235 | -3,160 | -10,724 | -25,008 | -42,059 |
| Net Income Continuous | -9,235 | -3,160 | -10,724 | -25,008 | -42,059 |
| Net Income | $-9,235 | $-3,160 | $-10,724 | $-25,008 | $-42,059 |
| EPS Basic Total Ops | -0.06 | -0.02 | -0.01 | -0.17 | -0.35 |
| EPS Basic Continuous Ops | -0.06 | -0.02 | 0.00 | -0.17 | -0.35 |
| EPS Diluted Total Ops | -0.06 | -0.02 | -0.01 | -0.17 | -0.35 |
| EPS Diluted Continuous Ops | -0.06 | -0.02 | 0.00 | -0.17 | -0.35 |
| EPS Diluted Before Non-Recurring Items | -0.06 | -0.02 | -0.07 | N/A | N/A |
| EBITDA(a) | $-5,022 | $-4,607 | $-9,908 | $-24,467 | $-41,973 |